Tower Trust & Investment Company’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.57M Sell
15,165
-608
-4% -$54.3K 0.95% 22
2026
Q1
$1.13M Buy
15,773
+65
+0.4% +$5.01K 0.74% 31
2025
Q4
$1.25M Buy
15,708
+132
+0.8% +$10.4K 0.78% 29
2025
Q3
$1.17M Sell
15,576
-188
-1% -$12.9K 0.79% 28
2025
Q2
$1.09M Buy
15,764
+336
+2% +$22K 0.77% 31
2025
Q1
$1.03M Buy
+15,428
New +$923K 0.83% 28

Other funds holding CVS

Tower Trust & Investment Company's CVS Position: Q2 2026 in Review

Tower Trust & Investment Company reduced its CVS Health (CVS) stake by 3.9% in Q2 2026, selling an estimated $54.3K and leaving 15,165 shares worth $1.57M. The position accounts for 0.95% of the portfolio, ranked #22.

Tower Trust & Investment Company first reported a position in CVS in Q1 2025 and has held it in 6 quarters since. 937 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Tower Trust & Investment Company held 15,165 shares of CVS Health worth $1.57M as of Q2 2026.
  • Tower Trust & Investment Company sold 608 CVS Health shares in Q2 2026, an estimated $54.3K.
  • CVS Health made up 0.95% of Tower Trust & Investment Company's portfolio in Q2 2026, its #22 holding.
  • Tower Trust & Investment Company first reported a position in CVS Health in Q1 2025 and has held it in 6 quarters since.
  • 937 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Tower Trust & Investment Company's 13F filing for Q2 2026, filed 9 Jul 2026.